| Overview |
| bsm-90355r-50µL |
| Arg2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Arg2 |
| 301-354/354 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 384 |
| P78540 |
| ARG2; Arginase 2; Arginase-2 Mitochondrial; Kidney-Type Arginase; Non-Hepatic Arginase; Arginase Type II; Type II Arginase; Arginase II; EC 3.5.3.1; L-Arginine Amidinohydrolase; L-Arginine Ureahydrolase; Nonhepatic Arginase; Kidney Arginase; EC 3.5.3 |
| Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz